ÃâÒßѧÊÔÌâ
^*cMry Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
`_ J^g&y~ 1. Fas(CD95)/FasL
C>w9
{h 2. common chain of cytokine receptor
rj2r# {[ 3 . TCR/CD3 complex
0p:ClM2O
4. negaive selection of thymocytes
\J,- <wF 5. artificial active immune
DJ
mQZ+{2 6. anti-idiotypic
=BqaGXr 7. IgSF
.q_uJ_qu- 8. Integrin
n3l"L|W^(< 9. chemokine
I |<+'G 10. B7/CD28
XvA0nEi ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
DSDl[;3O{s 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
}QWTPRn 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
=& Tu`m 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
zgq_0w~X 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
@R'g@+{I
U2[3
S\@ 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
aV?}+Y{# µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
(.quX@w"m Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
7G>0,'XC
1. B7/CD28
B(en5| 2. Th1 subset
I*vj26qvg 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
=|6^)lt$ 4. antibody affinity maturation
l|ZzG4]+l 5. AP-1
'.h/Y/oz 6. single chain variable fragment£¨ScFv£©
j quSR= 7. NK cell receptor
@KW+?maW 8. Zinkernagel-Doherty phenomenon
AG$-U2ap 9. Ig fold
n6%jhv9H 10. CD40/CD40L
j6R{ ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
t0asW5f 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
G7_"^r%c9; 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
B
yy-Cc 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
:S+U}Sm[ Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
L>5!3b=b 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
:LIKp; 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
y`B!6p
5j 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
TJw.e/ Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
~gi( 1<# £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
d"d)<f
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
C(t6;&H 1.Co-stimulators (or co-stimulating molecules)
kkE)zF 2.NK-kB
2`FsG/o\T~ 3.Immunoglobulin superfamily
^cmP 4.antigen-presenting cell (APC)
Ay"2W%([` 5.death domain
E-U;8cOMv 6.CCR and CXCR
dpGQ0EzH^ 7.Lectin (or mitogen)
3~3(G[w 8.Clusters of differentiation, CD)
hA,rSq 9.B7 family
xZ'`_x9l 10.Cytotoxic T lymphocyte, CTL)
|b'<XQ&l5 11.IL-15 and IL-15 receptor (IL-15R)
x+:,b~Skk 12.MHC restriction
Q0"F> %Cn 13.Affinity-chromatography
QWW7I.9r 14.Cyctosprin A, CsA
'ZZWH 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
b5
C}K ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
%J (
}D7-, 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
f_P+qm 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
>
%cWTC 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
ie)1 h Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
!e\R;bYM ÃâÒßѧרҵ£º
`~+a=Q 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
QGz3id6 Ïû»¯ÄÚ¿Æ£º
& Dl'*| 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
aj'8;E+ ѪҺ²¡Ñ§×¨Òµ£º
Pc;
14M 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
RdVis|7o Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
4C9"Q,o%& (רҵ»ù´¡: ÃâÒßѧ)
dpn&)?f Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
t5
v)6| 1. ADCC(antibody dependent cell-mediated cytotoxicity)
;s
B:s9M 2. »·æß¾úËØ(cyclosporin)
W;g+R- 3. KIR(killer cell inhibitory receptor)
GGQ(|?w 4. HLDA(human leucocyte differentiation antigen)
Sfa
m=.l 5. Interleukin 18(IL-18)
y~ 4nF 6. ÕûºÏËØ(integrin)
TN@JPoH 7. Fas/FasL
T&MS_E&; 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
83,1d*` 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
uZ?CVluP 10. Th1/Th2
#`)-$vUv^f 11. »ùÒòÒßÃç(DNAÒßÃç)
j{-7Pf8A 12. chemokines and chemokine receptor
+X(^Q@ 13. ÃâÒßÄÍÊÜ
R^kv!x;h 14. ¹²´Ì¼¤·Ö×Ó
i|{nj\6w^ 15. ËÀÍö½á¹¹Óò(death domain)
Rpd/9x.)& ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
B|$13dHfa 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
Mciq9{8&